Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 112 out of 109,758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31,226 | 30,630 |
| Total Cites | 474 | 523 |
| H-index | 11 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 54 | 54 |
| Total Cites to Single Authored Papers | 82 | 87 |
| Number of Single+First Authored Papers | 117 | 117 |
| Total Cites to Single+First Authored Papers | 209 | 226 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 285 | 310 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 408 | 433 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
9.37%
|
|
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 160 out of 84,246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37,957 | 31,009 |
| Total Cites | 359 | 431 |
| H-index | 10 | 12 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 48 | 48 |
| Total Cites to Single Authored Papers | 91 | 105 |
| Number of Single+First Authored Papers | 104 | 104 |
| Total Cites to Single+First Authored Papers | 222 | 256 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 262 | 300 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 321 | 366 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.18 |
| Self-Citation Percentage |
16.71%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.